Attorneys from across the US and Canada gathered last night on Sept. 12 at New York’s Essex House for the yearly LMG Life Sciences Awards, which honors top-ranking firms and individuals for outstanding legal work in the life sciences sector. This event, which is part of the 2018 research cycle for LMG Life Sciences, presented categories that recognize work in the four main practice areas covered by the guide, including regulatory, intellectual property, financial and corporate, and litigation and enforcement.
Among the highlights of the night was the induction of four exceptional life sciences attorneys into the Hall of Fame for their remarkable careers dedicated to clients in the industry.
Below is a list of this year’s award winners.
2018 Hall of Fame Inductees
Lori Cohen, Greenberg Traurig
Ron Dimock, DLA Piper
Anthony Figg, Rothwell Figg Ernst & Manbeck
Judith Hasko, Latham & Watkins
Catherine Polizzi, Morrison & Foerster
US Life Cycle Firm of the Year
Goodwin Procter
Canadian Life Cycle Firm of the Year
Torys
Regulatory
Regulatory Attorney of the Year: Pharmaceuticals
Daniel Kracov, Arnold & Porter
Regulatory Attorney of the Year: Medical Devices
Vernessa Pollard, McDermott Will & Emery
Regulatory Attorney of the Year: Pricing & Reimbursement
Alice Valder Curran, Hogan Lovells
Regulatory Rising Star
Alexander Varond, Goodwin Procter
Regulatory Firm to Watch
Arent Fox
Regulatory Firm of the Year
Hogan Lovells
Financial & Corporate
Corporate Attorney of the Year
Laura Berezin, Cooley
Licensing & Collaboration Attorney of the Year
Thomas Duley, King & Spalding
M&A Attorney of the Year
Adam Golden, Hogan Lovells
Corporate Firm of the Year
Cooley
Licensing & Collaboration Firm of the Year
Ropes & Gray
M&A Firm of the Year
Latham & Watkins
Venture Capital Firm of the Year
Wilson Sonsini Goodrich & Rosati
Financial & Corporate In-House Team of the Year
Celgene
Financial & Corporate Rising Star
Hannah Freeman, Ropes & Gray
Finance & Transactional Impact Deals of the Year
Celgene $9 billion acquisition of Juno Therapeutics
Eli Lilly $1.6 billion acquisition of ARMO biosciences
Gilead Sciences $11.9 billion acquisition of Kite Pharma
Roche $1.7 billion acquisition of Ignyta
Sanofi’s $11.6B Acquisition of Bioverativ, Inc.
Vertex Pharmaceuticals and CRISPR Therapeutics strategic research collaboration valued at 2.1 billion dollars.
Litigation & Enforcement
Product Liability Attorney of the Year
Lori Cohen, Greenberg Traurig
Product Liability Firm of the Year
Bradley Arant Boult Cummings
Government Investigations Attorney of the Year
Kimberly Dunne, Sidley Austin
Government Investigations Firm of the Year
Morgan Lewis & Bockius
Antitrust Litigator of the Year
Ted Hassi, Debevoise & Plimpton
Antitrust Firm of the Year
Weil Gotshal & Manges
Litigation Firm of the Year
Williams & Connolly
Intellectual Property
Intellectual Property Boutique Firm of the Year
Finnegan Henderson Farabow Garrett & Dunner
Hatch-Waxman Litigator of the Year – Branded
Charles Lipsey, Finnegan Henderson Farabow Garrett & Dunner
Hatch-Waxman Litigation Firm of the Year – Branded
Paul Hastings
Hatch-Waxman Litigator of the Year – Generic
George Lombardi, Winston & Strawn
Hatch-Waxman Litigation Firm of the Year – Generic
Winston & Strawn
Hatch-Waxman Impact Cases of the Year
Eli Lilly & Co. v. Dr. Reddy’s Laboratories
Helsinn Healthcare SA v. Teva Pharmaceuticals
Horizon Pharma v. Dr. Reddy’s Laboratories
Merck Sharp & Dohme v. Hospira
Millennium Pharmaceuticals v. Sandoz
Sanofi v. Watson Laboratories
General Patent Litigator of the Year – California
Jonathan Singer, Fish & Richardson
General Patent Litigator of the Year - District of Columbia
Matthew Wolf, Arnold & Porter
General Patent Litigator of the Year – Illinois
John Labbé, Marshall Gerstein & Borun
General Patent Litigator of the Year - New England
Lisa Pirozzolo, WilmerHale
General Patent Litigator of the Year - New York
Nicholas Groombridge, Paul Weiss Rifkind Wharton & Garrison
General Patent Litigation Firm of the Year
Fish & Richardson
Patent Impact Cases of the Year
Amgen v. Hospira
Biogen IDEC MA v. EMD Serono et al
GlaxoSmithKline et al v. Teva Pharmaceuticals
Idenix Pharmaceuticals et al v. Gilead Sciences
Saint Regis Mohawk Tribe, Allergan v. Mylan Pharmaceuticals et al
Patent Strategy & Management Attorney of the Year – California
Salima Merani, Knobbe Martens Olson & Bear
Patent Strategy & Management Attorney of the Year - District of Columbia
Eric Steffe, Sterne Kessler Goldstein & Fox
Patent Strategy & Management Attorney of the Year – Massachusetts
Anita Varma, White & Case
Patent Strategy & Management Attorney of the Year – Midwest
Pamela Cox, Marshall Gerstein & Borun
Patent Strategy & Management Attorney of the Year - New York
Ivor Elrifi, Cooley
Patent Strategy and Management Firm of the Year
Wolf Greenfield & Sacks
Post Grant Proceedings Attorney of the Year
Dorothy Whelan, Fish & Richardson
Inter-Partes Review Firm of the Year
Finnegan Henderson Farabow Garrett & Dunner
Intellectual Property Firm to Watch
Axinn Veltrop & Harkrider
Intellectual Property Rising Star
Thomas Fletcher, Williams & Connolly
Intellectual Property Firm of the Year
Fish & Richardson
Intellectual Property In-house Team of the Year
Gilead Sciences
Canada
Canadian Product Liability Attorney of the Year
Jill Lawrie, Blake Cassels & Graydon
Canadian Product Liability Firm of the Year
Torys
Canadian In-House Team of the Year
AstraZeneca
Canadian Patent Litigation Attorney of the Year
Gunars Gaikis, Smart & Biggar/Fetherstonhaugh
Canadian Patent Contentious Firm of the Year
Smart & Biggar/Fetherstonhaugh
Canadian Patent Non-Contentious Attorney of the Year
Eileen McMahon, Torys
Canadian Patent Non-Contentious Firm of the Year
Smart & Biggar/Fetherstonhaugh
Canadian Rising Star
Marian Wolanski, Belmore Neidrauer
Canadian IP Impact Cases of the Year
AbbVie et al v. Samsung Bioepis et al
Bristol-Myers Squibb v. Apotex
Pfizer v. Apotex
Canadian Financial & Corporate Attorney of the Year
Joseph Garcia, Blake Cassels & Graydon
Canadian Financial & Corprate Firm of the Year
Torys
Canadian Deals of the Year
Aurora C$1.1 billion acquisition of CanniMed
Sale of Merus Labs to Norgine B.V. for $342 million
Zymeworks Inc. $64 million initial public offering